James E. Delmore

704 total citations
25 papers, 520 citations indexed

About

James E. Delmore is a scholar working on Surgery, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, James E. Delmore has authored 25 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Obstetrics and Gynecology and 8 papers in Reproductive Medicine. Recurrent topics in James E. Delmore's work include Endometrial and Cervical Cancer Treatments (7 papers), Ovarian cancer diagnosis and treatment (7 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). James E. Delmore is often cited by papers focused on Endometrial and Cervical Cancer Treatments (7 papers), Ovarian cancer diagnosis and treatment (7 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). James E. Delmore collaborates with scholars based in United States. James E. Delmore's co-authors include Brigitte Miller, Douglas V. Horbelt, Jim Y. Wan, Elvio G. Silva, David M. Gershenson, Linda M. Frazier, Susan G. Arbuck, Daniel K. Roberts, Harry J. Long and Katherine Y. Look and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and European Journal of Cancer.

In The Last Decade

James E. Delmore

25 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James E. Delmore United States 13 245 176 149 135 73 25 520
Ron E. Swensen United States 15 218 0.9× 148 0.8× 187 1.3× 183 1.4× 64 0.9× 30 549
Tom Oliver Canada 8 188 0.8× 233 1.3× 132 0.9× 101 0.7× 44 0.6× 9 537
Sinan Özalp Türkiye 15 182 0.7× 263 1.5× 106 0.7× 94 0.7× 78 1.1× 62 677
Jitti Hanprasertpong Thailand 17 210 0.9× 288 1.6× 217 1.5× 102 0.8× 138 1.9× 52 672
Ramey D. Littell United States 19 431 1.8× 390 2.2× 160 1.1× 129 1.0× 107 1.5× 45 941
Tracie Miles United Kingdom 10 262 1.1× 402 2.3× 181 1.2× 87 0.6× 48 0.7× 17 611
Amelia Jernigan United States 13 179 0.7× 198 1.1× 146 1.0× 155 1.1× 43 0.6× 47 462
Simona Moroni Italy 16 328 1.3× 229 1.3× 180 1.2× 36 0.3× 71 1.0× 20 665
Zeynep Özsaran Türkiye 13 79 0.3× 188 1.1× 156 1.0× 153 1.1× 34 0.5× 48 499
Nathaniel Jones United States 14 159 0.6× 161 0.9× 200 1.3× 68 0.5× 84 1.2× 44 524

Countries citing papers authored by James E. Delmore

Since Specialization
Citations

This map shows the geographic impact of James E. Delmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Delmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Delmore more than expected).

Fields of papers citing papers by James E. Delmore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Delmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Delmore. The network helps show where James E. Delmore may publish in the future.

Co-authorship network of co-authors of James E. Delmore

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Delmore. A scholar is included among the top collaborators of James E. Delmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Delmore. James E. Delmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Fanglong, et al.. (2018). Appropriate Use of Prophylactic Antibiotic Agents in Gynecologic Surgeries at a Midwestern Teaching Hospital. Surgical Infections. 19(4). 397–402. 4 indexed citations
2.
Bender, David, Michael W. Sill, Heather A. Lankes, et al.. (2015). A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology. 138(3). 507–512. 48 indexed citations
3.
Bender, David, Michael W. Sill, Heather A. Lankes, et al.. (2015). A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. PMC. 14 indexed citations
4.
Bender, David, Michael W. Sill, Heather A. Lankes, et al.. (2015). A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group (GOG) study. Gynecologic Oncology. 138. 2–2. 2 indexed citations
5.
6.
Pham, Huyen Q., Benjamin Schwartz, James E. Delmore, et al.. (2013). Pharmacodynamic stimulation of thrombogenesis by angiotensin (1–7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy. Cancer Chemotherapy and Pharmacology. 71(4). 965–972. 18 indexed citations
7.
Frazier, Linda M., et al.. (2010). Comparison of Focus Groups on Cancer and Employment Conducted Face to Face or by Telephone. Qualitative Health Research. 20(5). 617–627. 36 indexed citations
8.
Frazier, Linda M., et al.. (2009). Employment and Quality of Survivorship among Women with Cancer: Domains not Captured by Quality of Life Instruments. Cancer Control. 16(1). 57–65. 19 indexed citations
9.
Delmore, James E., et al.. (2004). Blunt Abdominal Trauma with Ruptured 16-Week Cornual Ectopic Pregnancy. The American Surgeon. 70(6). 559–560. 3 indexed citations
10.
Orr, James W., Fredrick J. Montz, James Barter, et al.. (2003). Continuous abdominal fascial closure: a randomized controlled trial of poly(l-lactide/glycolide). Gynecologic Oncology. 90(2). 342–347. 8 indexed citations
11.
Omura, George, Mark F. Brady, Katherine Y. Look, et al.. (2003). Phase III Trial of Paclitaxel at Two Dose Levels, the Higher Dose Accompanied by Filgrastim at Two Dose Levels in Platinum-Pretreated Epithelial Ovarian Cancer: An Intergroup Study. Journal of Clinical Oncology. 21(15). 2843–2848. 76 indexed citations
12.
Horbelt, Douglas V., et al.. (1999). Ultrastructural Interactions in the Microvasculature of Human Endometrial Adenocarcinoma. Gynecologic Oncology. 73(1). 76–86. 5 indexed citations
13.
Poplin, Elizabeth, Pengfei Liu, James E. Delmore, et al.. (1999). Phase II Trial of Oral Etoposide in Recurrent or Refractory Endometrial Adenocarcinoma: A Southwest Oncology Group Study. Gynecologic Oncology. 74(3). 432–435. 20 indexed citations
14.
Kudelka, Andrzej P., Rodger J. Winn, Creighton L. Edwards, et al.. (1997). An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Anti-Cancer Drugs. 8(7). 657–661. 47 indexed citations
15.
Miller, Brigitte, et al.. (1997). Prognostic factors in adult granulosa cell tumor of the ovary. Cancer. 79(10). 1951–1955. 114 indexed citations
16.
Horbelt, Douglas V., et al.. (1996). The nuclear channel system in endometrial adenocarcinoma exposed to medroxyprogesterone acetate. Human Pathology. 27(1). 9–14. 6 indexed citations
17.
Delmore, James E., et al.. (1995). Atypical squamous cells of undetermined significance: community incidence and management review.. PubMed. 96(3). 133–4. 1 indexed citations
18.
Delmore, James E., Douglas V. Horbelt, & K. James Kallail. (1992). Cervical conization: cold knife and laser excision in residency training.. PubMed. 79(6). 1016–9. 11 indexed citations
19.
Delmore, James E., et al.. (1989). Experience with the Groshong long-term central venous catheter. Gynecologic Oncology. 34(2). 216–218. 26 indexed citations
20.
Delmore, James E., et al.. (1987). Preoperative radiotherapy for early endometrial carcinoma. Gynecologic Oncology. 28(1). 34–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ron E. Swensen Breakdown of academic impact, for papers by Tom Oliver Breakdown of academic impact, for papers by Sinan Özalp Breakdown of academic impact, for papers by Jitti Hanprasertpong Breakdown of academic impact, for papers by Ramey D. Littell Breakdown of academic impact, for papers by Tracie Miles Breakdown of academic impact, for papers by Amelia Jernigan Breakdown of academic impact, for papers by Simona Moroni Breakdown of academic impact, for papers by Zeynep Özsaran Breakdown of academic impact, for papers by Nathaniel Jones
Rankless by CCL
2026